Metabolic profile of intact tissue from uterine leiomyomas using high-resolution magic-angle-spinning 1H NMR spectroscopy

NMR in Biomedicine

Volumn 23, Issue 10, 2010, Pages 1137-1145

  Mazzei, Pierluigi ^a,b   Piccolo, Alessandro ^a   Nugnes, Loredana ^a   Mascolo, Massimo ^a   De Rosa, Gaetano ^c   Staibano, Stefania ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c REFERRAL CANCER CENTER OF BASILICATA   (Italy)

Author keywords

Ex vivo NMR; HRMAS NMR; Metabolomics; Principal component analysis; Uterine leiomyomas

Indexed keywords

EX-VIVO; HR-MAS NMR; METABOLOMICS; PRINCIPAL COMPONENTS; UTERINE LEIOMYOMAS;

AMINO ACIDS; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SPECTRUM ANALYSIS; TISSUE;

PRINCIPAL COMPONENT ANALYSIS;

GLUTAMIC ACID; GLUTAMINE; TAURINE;

ADULT; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HETERONUCLEAR SINGLE QUANTUM COHERENCE; HIGH RESOLUTION MAGIC ANGLE SPINNING PROTON NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROSCOPY; TISSUE TYPES; TOTAL CORRELATION SPECTROSCOPY; UTERUS MYOMA;

FEMALE; HEALTH; HUMANS; LEIOMYOMA; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; PROTONS; UTERINE NEOPLASMS;

EID: 78650295673     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1540     Document Type: Article

References (26)

1. Buttram VC Jr, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981; 36: 433-445.
2. Celik O, Sarac K, Hascalik S, Alkan A, Mizrak B, Yologlu S. Magnetic resonance spectroscopy features of uterine leiomyomas. Gynecol Obstet Invest. 2004; 58: 194-201.
3. Schlaerth JB, d'Ablaing G, Mishell DR Jr, Leibshon S. Leiomyosarcoma in a series of hysterectomies performed for presumed leiomyomas. Am J Obstet Gynecol. 1990; 162: 968-976.
4. Duelhom M, Lundorf E, Hansen ES, Ledertoug S, Olesen F. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol. 2002; 186: 409-415.
5. Jeon Y-T, Kim JW, Park N-H, Song Y-S, Kang S-B, Lee H-P. DNA repair gene XRCC1 Arg399Gln polymorphism is associated with increased risk of uterine leiomyoma. Hum Reprod. 2005; 20: 1586-1589.
6. Tsibris JCM, Maas S, Segars JH, Nicosia SV, Enkemann SA, O'Brien WF, Spellacy WN. New potential regulators of uterine leiomyomata from DNA arrays: the ionotropic glutamate receptor GluR2q. Biochem Biophys Res Commun. 2003; 312: 249-254.
7. Lattuada D, Viganó P, Mangioni S, Sassone J, Di Francesco S, Vignali M, Di Blasio AM. Accumulation of retinoid X receptor-α in uterine leiomyomas is associated with a delayed ligand-dependent proteasome-mediated degradation and an alteration of its transcriptional activity. Mol Endocrinol. 2007; 21: 602-612.
8. Tsibris JCM, Porter KB, Jazayeri A, Tzimas G, Nau H, Huang H, Kuparadze K, Porter GW, O'Brien WF, Spellacy WN. Human uterine leiomyomata express higher levels of peroxisome proliferator activated receptor γ, retinoid X receptor α, and all-trans retinoic acid than myometrium. Cancer Res. 1999; 59: 5737-5744.
9. Luo X, Ding L, Xu J, Williams RS, Chegini N. Leiomyoma and myometrial gene expression profiles and their responses to gonadotropin-releasing hormone analog therapy. Endocrinol. 2005; 146: 1074-1096.
10. Zaitseva M, Vollenhoven BJ, Rogers PAW. Retinoic acid pathway genes show significantly altered expression in uterine fibroids when compared with normal myometrium. Molec Human Rep. 2007; 13: 577-585.
11. Cheng LL, Chang IW, Louis DA, Gonzales RG. Correlation of high-resolution magic angle spinning proton magnetic resonance with histopathology of intact human brain tumour specimens. Cancer Res. 1998; 58: 1825-1832.
12. Beckonert O, Monnerjahn J, Bonk U, Leibfritz D. Visualizing metabolic changes in breast-cancer tissue using 1H-NMR spectroscopy and self-organizing maps. NMR Biomed. 2003; 16: 1-11.
13. 1H NMR properties of N-acetylaspartylglutamate in extracts of nervous tissue of the rat. NMR Biomed. 2005; 5: 43-47.
14. 1H NMR of tissue extracts in SIV-infected macaques. NMR Biomed. 2005; 18: 242-251.
15. Gribbestad IS, Fjösne HE, Haugen OA, Nilsen G, Krane J, Petersen SB, Kvinnsland S. In vitro proton NMR spectroscopy of extracts from human breast tumours and non-involved breast tissue. Anticancer Res. 1993; 13: 1973-1980
16. Cheng LL, Wu C, Smith MR, Gonzales RG. Non-destructive quantitation of spermine in human prostate tissue samples using HRMAS 1H NMR spectroscopy at 9.4 T. Febs Lett. 2001; 494: 112-116.
17. 1H nuclear magnetic resonance spectroscopy of liver tissues. Anal Biochem. 2003; 323: 26-32.
18. Schenetti L, Mucci A, Parenti F, Cagnoli R, Righi V, Tosi MR, Tugnoli V. HR-MAS NMR spectroscopy in the characterization of human tissues: application to healthy gastric mucosa. Concept Magnetic Res. 2006; 28A: 430-443.
19. 1H nuclear magnetic resonance spectroscopy. J Pharm Biomed Anal. 1998; 17: 125-132.
20. Duarte IF, Stanley EG, Holmes E, Lindon JC, Gil AM, Tang H, Ferdinand R, McKee CG, Nicholson JK, Vilca-Melendez H, Heaton N, Murphy GM. Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy. Anal Chem. 2005; 77: 5570-5578.
21. Taylor JL, Wu CL, Cory D, Gonzalez RG, Bielecki A, Cheng LL. High-resolution magic angle spinning proton NMR analysis of human prostate tissue with slow spinning rates. Magn Reson Med. 2003; 50: 627-632.
22. Sitter B, Sonnewald U, Spraul M, Fjösne HE, Gribbestad IS. High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed. 2002; 15: 327-337.
23. 1H MRS study of human high grade gliomas. NMR Biomed. 2004; 17: 191-205.
24. 1H NMR spectroscopy studies of blood plasma and other biofluids. NMR Biomed. 1994; 7: 243-247.
25. Sivaraja M, Turner C, Souza K, Singer S. Ex-vivo 2-dimensional proton nuclear-magnetic-resonance spectroscopy of smooth-muscle tumors - advantages of total correlated spectroscopy over homonuclear J-correlated spectroscopy. Cancer Res. 1994; 54: 6037-6040.
26. Tsibris JCM, Maas S, Segars JH, Nicosia SV, Enkemann SA, O'Brien WF, Spellacy WN. New potential regulators of uterine leiomyomata from DNA arrays: the ionotropic glutamate receptor GluR2. Biochem Biophys Res Commun. 2003; 312: 249-254.